e-learning
resources
Monograph
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases
R. Westhovens, F. De Keyser, F.H.J. van den Hoogen, B. Hellmich, C.G. Kallenberg, B. Lauwerys, P. Schenk, D.J. Abraham, B.N. Lambrecht, J.C. Grutters, M. Demedts, and the co-workers of working group 1
Source:
Eur Respir Mon; 2006: 34: 1–26
Journal Issue:
Pulmonary Manifestations of Systemic Diseases
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Westhovens, F. De Keyser, F.H.J. van den Hoogen, B. Hellmich, C.G. Kallenberg, B. Lauwerys, P. Schenk, D.J. Abraham, B.N. Lambrecht, J.C. Grutters, M. Demedts, and the co-workers of working group 1. The clinical spectrum and pathogenesis of pulmonary manifestations in connective tissue diseases. Eur Respir Mon; 2006: 34: 1–26
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
IgG4 disease and the lung
Dyspnoea in a patient with Osler's disease
Aortic dilation, Marfan disease and aortic dissection: links with OSA and impact of treatment
Related content which might interest you:
Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27
Year: 2005
Features of pulmonary involvement in patients with diffuse connective tissue diseases
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Interstitial lung disease with autoimmune features
Source: Eur Respir Mon 2011; 54: 104-117
Year: 2011
Clinico-radiological profile of connective tissue diseases related interstitial lung diseases
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Features of pulmonary involvement in patients with diffuse connective tissue diseases depending on a nosological form
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011
Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015
Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Comparison of registries of interstitial lung diseases in three European countries
Source: Eur Respir J 2001; 18: 114S-118S
Year: 2001
Morphologic evaluation of lung in a scleroderma-like rabbit model
Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease
Year: 2006
Interstitial lung disease
Source: Eur Respir Rev 2013; 22: 26-32
Year: 2013
Interstitial lung disease in patients with connective tissue diseases - a report of 3 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 668s
Year: 2004
What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis!
Source: International Congress 2015 – Connective tissue disorders
Year: 2015
Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement
Source: Eur Respir J 2009; 33: 882-896
Year: 2009
Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up?
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy},
Source: Eur Respir J 2012; 40: 641-648
Year: 2012
Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017
Pattern and impact of rheumatology referral in patients with ILD and autoimmune features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept